| 前收市價 | 6.82 |
| 開市 | 6.82 |
| 買盤 | 6.49 x 500 |
| 賣出價 | 6.55 x 400 |
| 今日波幅 | 6.48 - 6.88 |
| 52 週波幅 | 1.28 - 16.24 |
| 成交量 | |
| 平均成交量 | 1,020,833 |
| 市值 | 460.153M |
| Beta 值 (5 年，每月) | 0.89 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.35 |
| 業績公佈日 | 2024年8月08日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 18.75 |
InvestorPlaceOpportunity Alert: 3 Undiscovered Stocks About to Explode on Wall Street’s Radar
Three equities stand out among the plethora of alternatives as possible Wall Street game-changers. Each represents a distinct industry: energy, cannabis and biotechnology. The first company is a shining light in biotechnology due to its innovative cell therapy platform. It shows great potential for treating autoimmune disorders such as refractory lupus nephritis. Similarly, the second one takes advantage of the energy sector’s volatility by maximizing cash flow. It does this through solid financ
Investor's Business DailyWhy Nkarta Stock Just Boomeranged Following A Massive Dive On Friday
Nkarta stock surged Monday — partially reversing a 31% dive on Friday — after unveiling promising test results for its lymphoma treatment.
Investor's Business DailyWhy Top 1% Biotech Stock Nkarta Just Plummeted, Undercutting Its 50-Day Line
Top-notch Nkarta stock tumbled Friday after the biotech company deprioritized a cancer drug in favor of an experimental lupus treatment.
